Limited Competition: National Primate Research Centers (P51) (Clinical Trials Not Allowed)
Issued by National Institutes of Health · via Grants.gov — US federal funding opportunities
- Published
- 26 May 2023
- Closes
- 25 Sept 2026, 23:59 UTC
- Reference
- PAR-23-126
- Location
- United States
- Sector
- Healthcare & Pharma
Details
This funding opportunity announcement (FOA) encourages grant applications that support the activities of the National Primate Research Centers (NPRCs). Nonhuman primates (NHPs) are most closely related to humans, both physiologically and genetically. Therefore, NHPs are critical animal models for basic and translational research aimed at understanding human biology, both in normal and diseased states. Proper husbandry and management of NHPs require specialized physical and intellectual resources, which are most effectively and economically provided in centralized primate centers, the resources of which are made available to investigators on a national basis. The NPRCs provide these resources to investigators/grantees who utilize NHPs in biomedical research and thereby complement and help enable the missions of the NIH Institutes and Centers. Eligibility: Other Eligible Applicants include the following:Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.See full Notice of Funding Opportunity for additional details on eligibility.
CFDA number(s): 93.351
Federal funding opportunity published on Grants.gov. Applications are submitted through Grants.gov — see the official listing.
Before you bid on this tender
A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.
- Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
- Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
- Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
- Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
- Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
- Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.
More Healthcare & Pharma tenders
- Prevention AssistantMENTOR · Venezuela
- Annual maintenance contract for the Civil work in Centenary Super Specialty building S.S. Hospital, IMS, BHU, Varanasi.Banaras Hindu University · India
- Accessories for Multipara Monitor Model Ultima Prime Make BPLDr. Ram Manohar Lohia Hospital · Procurement Section · India
- CAMC for HPLC SystemCouncil of Scientific and Industrial Research · IGIB-Delhi - CSIR · Purchase-IGIB - CSIR · India
- Acquérir 6 véhicules de transport adaptés pour l'acheminement des produits de santé dans les 6 wilayasUGP SWEDD
FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.
Verify & apply on the official portal →